|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ANZCTR |
|
Last refreshed on:
|
13 January 2020 |
|
Main ID: |
ACTRN12616001246471 |
|
Date of registration:
|
06/09/2016 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Platelet Activation in Retinal Vein Occlusion
|
|
Scientific title:
|
Platelet Activation in Branch Retinal Vein Occlusion |
|
Date of first enrolment:
|
01/08/2016 |
|
Target sample size:
|
60 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://anzctr.org.au/ACTRN12616001246471.aspx |
|
Study type:
|
Observational |
|
Study design:
|
Purpose: Screening;Duration: Longitudinal;Selection: Defined population;Timing: Prospective;
|
|
Phase:
|
Not Applicable
|
|
|
Countries of recruitment
|
|
Turkey
| | | | | | | |
|
Contacts
|
|
Name:
|
Prof Mehmet CITIRIK
|
|
Address:
|
SB Ankara Ulucanlar Eye Education and Research Hospital.
Ulucanlar Cad. No: 59 06230 ALTINDAG/ANKARA/TURKEY
Turkey |
|
Telephone:
|
+903123126261 |
|
Email:
|
mcitirik@hotmail.com |
|
Affiliation:
|
|
|
|
Name:
|
Dr Ali Keles
|
|
Address:
|
SB Ankara Ulucanlar Eye Education and Research Hospital.
Ulucanlar Cad. No: 59 06230 ALTINDAG/ANKARA/TURKEY
Turkey |
|
Telephone:
|
+903123126261 |
|
Email:
|
kelesali2706@gmail.com |
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: We included the BRVO patients with posterior segment involvement.. The diagnosis of BRVO will reached using funud photography, flourescein angiography, and optical cohrence tomography. Patients and healthy volunteers that were matched for age and gender included in this study
Exclusion criteria: Patients and healthy volunteers who were on any kind of medication including corticosteroid and immunosuppressive therapy, who had smoking (smoke more than 1 cigarette per day) and drinking ( >1 standard drink per week) habits, or who had history of systemic and ocular disease will not included in the study
Age minimum:
40 Years
Age maximum:
80 Years
Gender:
Both males and females
|
|
Health Condition(s) or Problem(s) studied
|
|
Blood - Other blood disorders
|
|
Eye - Diseases / disorders of the eye
|
Branch Retinal Vein Occlusion;
Branch Retinal Vein Occlusion
|
|
Intervention(s)
|
|
Blood sampled will be collected in patients with acute branch retinal vein occlusion (BRVO). Platellet activation will be assessed. Patients with BRVO will be treated with conventional therapy. Duration of observation is 1 month.
|
|
Primary Outcome(s)
|
|
Mean platelet volume count will be assessed using serum samples.[1 month post enrolment. These participants will be followed-up for 1 month]
|
|
Platelletcrit count will be assessed using serum samples.[1 month post enrolment. These participants will be followed-up for 1 month]
|
|
platelet distribution width count will be assessed using serum samples[1 month post enrolment. These participants will be followed-up for 1 month]
|
|
Secondary Outcome(s)
|
|
None[None]
|
|
Secondary ID(s)
|
|
Nil Known
|
|
Source(s) of Monetary Support
|
|
Ankara Ulucanlar Eye Education and research hospital.
|
|
Ethics review
|
Status: Approved
Approval date:
Contact:
Ankara Numune Training and Research Hospital
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|